POLİFARMA CORPORATE VIDEO

Click to
Watch

We are proud to have successfully completed CPHI Barcelona 2023, one of the most important fairs of the pharmaceutical and healthcare industry in the international arena.

According to the 2022 R&D 250 Research conducted by TurkishTime,
Polifarma is; One of the '’250 Companies with the Most R&D Spending’’

Global Business Outlook 'The Most Innovative Pharmaceutical Company in R&D' Award to Polifarma!

Polifarma Has Signed a License Agreement With One Of The Major Players of South Korean Pharmaceutical Companies; Dong-A ST.

Click on the link to read the news of the license agreement signed between Polifarma and Dong-A ST for the NESP® Biosimilar product DA-3880.

We participated in CPHI Frankfurt 2022 which is the most important fair in the pharmaceutical industry.

We held our annual meeting in North Cyprus.

One More Award to Polifarma!

Our ‘Polifarma Street’ Project was awarded in ‘The Most Successful Internal Training Programme’ category by Golden Pulse Awards.

Another award to Polifarma by Altın Havan Awards for the 3rd time…

Polifarma was awarded in ‘Investment’ category by ‘ALTIN HAVAN Awards’.

As Polifarma, we participated in the BioExpo Fair, as the main sponsor of the exhibition.